Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT00308269
Eligibility Criteria:
Inclusion Criteria:
* Histological or cytological diagnosis of neoplasm
* No effective standard therapeutic options
* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
* \>=4 weeks post therapeutic radiation of chemotherapy \>=6 weeks for nitrosoureas and mitomycin C) and recovery from associated toxicities
* Negative serum pregnancy test for women of child-bearing potential and willingness to practice contraceptive methods
* Adequate bone marrow reserve, renal, and hepatic function
Exclusion Criteria:
* Concurrent hematological malignancies
* Women who are pregnant or lactating
* Evidence of symptomatic brain metastases
* Receiving concomitant anticancer therapy (excluding supportive care)
* Requires palliative radiotherapy at time of study entry
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00308269
Study Brief:
Protocol Section:
NCT00308269